Summer Street analyst Carol Werther reiterated a Buy rating on Celgene (NASDAQ: CELG) and boosted her price target from $109 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE